The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer

Ovarian cancer is the leading cause of gynecological cancer related death in females worldwide. Our previous study demonstrated that decreased expression of microRNA (miR-126) promoted ovarian cancer angiogenesis and invasion by targeting VEGF-A. This study aimed to evaluate the clinical validity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lin, Han, Qing, Cai, Jing, Xiao, Man, Huang, Da, Cao, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981431/
https://www.ncbi.nlm.nih.gov/pubmed/36862865
http://dx.doi.org/10.1097/MD.0000000000033085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981431/
https://www.ncbi.nlm.nih.gov/pubmed/36862865
http://dx.doi.org/10.1097/MD.0000000000033085

Ejemplares similares